Meritage Portfolio Management Novo Nordisk A S Transaction History

Meritage Portfolio Management

  • $1.63 Billion
  • Q3 2024

A detailed history of Meritage Portfolio Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Meritage Portfolio Management holds 203,793 shares of NVO stock, worth $17.8 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
203,793
Previous 206,023 1.08%
Holding current value
$17.8 Million
Previous $29.4 Million 17.49%
% of portfolio
1.49%
Previous 1.86%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$119.07 - $145.42 $265,526 - $324,286
-2,230 Reduced 1.08%
203,793 $24.3 Million
Q2 2024

Aug 08, 2024
SELL
$122.71 - $146.91 $4.07 Million - $4.87 Million
-33,177 Reduced 13.87%
206,023 $29.4 Million
Q1 2024

Apr 29, 2024
SELL
$102.11 - $135.92 $1.01 Million - $1.34 Million
-9,859 Reduced 3.96%
239,200 $30.7 Million
Q4 2023

Feb 02, 2024
BUY
$87.78 - $105.45 $1.42 Million - $1.7 Million
16,159 Added 6.94%
249,059 $25.8 Million
Q3 2023

Oct 30, 2023
BUY
$90.94 - $199.54 $10.6 Million - $23.3 Million
116,578 Added 100.22%
232,900 $21.2 Million
Q2 2023

Jul 31, 2023
BUY
$155.98 - $172.65 $10.2 Million - $11.3 Million
65,508 Added 128.92%
116,322 $18.8 Million
Q1 2023

Apr 25, 2023
BUY
$132.34 - $159.14 $6.72 Million - $8.09 Million
50,814 New
50,814 $8.09 Million
Q1 2022

Apr 25, 2022
SELL
$93.1 - $112.54 $6.12 Million - $7.4 Million
-65,775 Closed
0 $0
Q4 2021

Jan 28, 2022
BUY
$95.88 - $117.08 $81,977 - $100,103
855 Added 1.32%
65,775 $7.37 Million
Q3 2021

Oct 26, 2021
BUY
$84.42 - $106.62 $50,989 - $64,398
604 Added 0.94%
64,920 $6.23 Million
Q2 2021

Jul 26, 2021
BUY
$67.66 - $84.76 $115,360 - $144,515
1,705 Added 2.72%
64,316 $5.39 Million
Q1 2021

Apr 27, 2021
BUY
$67.06 - $75.82 $717,877 - $811,653
10,705 Added 20.62%
62,611 $4.22 Million
Q4 2020

Feb 03, 2021
BUY
$63.89 - $73.8 $203,297 - $234,831
3,182 Added 6.53%
51,906 $3.63 Million
Q3 2020

Oct 26, 2020
BUY
$63.69 - $70.22 $19,807 - $21,838
311 Added 0.64%
48,724 $3.38 Million
Q2 2020

Jul 27, 2020
SELL
$58.54 - $67.94 $81,312 - $94,368
-1,389 Reduced 2.79%
48,413 $3.17 Million
Q1 2020

Apr 27, 2020
SELL
$49.46 - $64.78 $113,807 - $149,058
-2,301 Reduced 4.42%
49,802 $3 Million
Q4 2019

Jan 27, 2020
SELL
$49.86 - $58.26 $39,389 - $46,025
-790 Reduced 1.49%
52,103 $3.02 Million
Q3 2019

Oct 25, 2019
BUY
$47.54 - $53.43 $283,053 - $318,122
5,954 Added 12.68%
52,893 $2.74 Million
Q2 2019

Jul 30, 2019
BUY
$46.79 - $52.47 $2.2 Million - $2.46 Million
46,939 New
46,939 $2.4 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Meritage Portfolio Management Portfolio

Follow Meritage Portfolio Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email